微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | -0.03% | -105.57% | 92.2% | 118/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | -0.4% | 48.05% | -8.11% | 116/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | -0.37% | -562.5% | 97.07% | 120/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | -12.61% | -453.07% | -2351.79% | 124/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 0.56% | 276.6% | 172.73% | 106/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -0.77% | -220.83% | -1062.5% | 112/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.08% | -84.62% | 103.51% | 111/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -2.28% | -200.88% | -1633.29% | 109/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 0.15% | -96.33% | 161.96% | 113/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -0.24% | -111.17% | -146.15% | 115/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.52% | -64.14% | -76.99% | 105/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 2.26% | -16.61% | -44.2% | 86/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 4.05% | 3.58% | 88.47% | 80/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.15% | -6.97% | 48.2% | 81/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.45% | 12.4% | -46.49% | 71/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.71% | -52.54% | -30.69% | 91/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 3.91% | -53.45% | 69.26% | 74/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.31% | -60.45% | 79.07% | 80/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.29% | -61.14% | -77.41% | 79/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 5.71% | 220.97% | -32.02% | 74/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 8.4% | 170.18% | 43.84% | 49/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.84% | 173.09% | 75.9% | 41/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 3.32% | 173.61% | 170.34% | 36/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | -4.72% | -244.34% | 60.57% | 115/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | -11.97% | -365.41% | -49.81% | 110/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | -7.99% | -456.7% | -77.16% | 121/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | -4.51% | -192.04% | -237.92% | 107/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 3.27% | 289.29% | -27.49% | 99/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 4.51% | 139.89% | 101.34% | 73/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.24% | 27.27% | -54.29% | 81/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 4.9% | 255.07% | 483.33% | 11/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 0.84% | -61.29% | -55.32% | 115/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 1.88% | 40.3% | 6.82% | 91/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.76% | 47.9% | 27.54% | 85/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.38% | 10.4% | -36.41% | 69/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 2.17% | 1305.56% | 61.94% | 106/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 1.34% | 10.74% | 12.61% | 89/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.19% | 26.6% | -4.8% | 89/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.25% | 104.92% | 794.44% | 59/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | -0.18% | -109.94% | -114.88% | 104/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 1.21% | 2.54% | 28.72% | 73/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 0.94% | -39.74% | 54.1% | 77/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.61% | -39.6% | -66.3% | 67/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |